To determine how the COVID-19 pandemic impacts patients with chronic disease medication adherence.
Methods
Four electronic databases, PubMed, MEDLINE, Web of Science, and CINAHL Plus Full Text, were searched for literature between 2019 and 2021. Abstracts and later full texts were independently screened by the authors of this review using inclusion and exclusion criteria to determine relevance to our study. Joanna Briggs Institute (JBI) critical appraisal tools were used to assess the quality of included texts. Relevant information and data from the included texts were extracted into tables for data synthesis and analysis.
Results
Ten studies met the study criteria, the most popular study design was cross-sectional design (n = 9, 90.0%), others were case series (n = 1, 10.0%). Barriers to medication adherence and facilitators of medication adherence were the major two themes that participants reported regarding the impact of COVID-19 on medication adherence. Moreover, these two main themes have been organized in sub-themes that are dealt with in-depth.
Discussion
Our results could heighten healthcare providers, stakeholders, and policy leaders’ awareness of providing appropriate support for chronic disease patients, especially regarding medication adherence. Future research incorporating programs that support patients’ needs is recommended.
HarrisRE. Epidemiology of chronic disease: global perspectives. Burlington, MA, USA: Jones & Bartlett Learning, 2019.
2.
RitchieHRoserM. Causes of death. Published online at Our World in Data. 2018. Retrieved from: 'https://ourworldindata.org/causes-of-death' [Online Resource].
3.
GrapsaEPanteliasKNtentaE, et al. Caregivers’ experience in patients with chronic diseases. Soc Work Health Care2014; 53: 670–678.
4.
HuangCWangYLiX, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet2020; 395: 497–506.
5.
ZhuNZhangDWangW, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med2020; 382: 727–733.
6.
RuksakulpiwatS. The impact of COVID-19 on patients with stroke: an integrative review. J Health Res2021. ahead-of-print.
7.
ColemanCILimoneBSobierajDM, et al. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm2012; 18: 527–539.
8.
MendisS. Prevention and care of stroke in low-and middle-income countries; the need for a public health perspective. Int J Stroke2010; 5: 86–91.
9.
PandianJDGallSLKateMP, et al. Prevention of stroke: a global perspective. The Lancet2018; 392: 1269–1278.
10.
KripalaniSYaoXHaynesRB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med2007; 167: 540–549.
11.
UsherwoodT. Encouraging adherence to long-term medication. Aust Prescr2017; 40: 147.
12.
Al AlShaikhSQuinnTDunnW,et al.Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: a systematic review and meta-analyses. Eur Stroke J2016; 1: 65–75.
13.
MoherDLiberatiATetzlaffJ,et al.Reprint—preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther2009; 89: 873–880.
14.
MoolaSMunnZTufanaruC, et al. Chapter 7: systematic reviews of etiology and risk. Joanna Briggs Institute Reviewer’s Manual The Joanna Briggs Institute. 2017; 5: 217–267.
15.
MunnZBarkerTHMoolaS, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI evid Synth2020; 18: 2127–2133.
16.
MckenzieGWillisCShieldsN. Barriers and facilitators of physical activity participation for young people and adults with childhood-onset physical disability: a mixed methods systematic review. Dev Med Child Neurol2021; 63: 914–924.
17.
SandelowskiMVoilsCIBarrosoJ. Defining and designing mixed research synthesis studies. Res Sch: a Nationally Refereed Journal Sponsored by the Mid-South Educational Research Association and the University of Alabama. 2006; 13: 29.
18.
GulZBAtakliHD. Effect of the COVID-19 pandemic on drug compliance and stigmatization in patients with epilepsy. Epilepsy Behav2021; 114: 107610.
19.
CostantinoFBahierLTaranconLC, et al. COVID-19 in French patients with chronic inflammatory rheumatic diseases: clinical features, risk factors and treatment adherence. JOINT BONE SPINE2021; 88: 105095.
20.
ZakariaOMAlbshrFAAljarrashKM,et al.Does COVID-19 pandemic affect medication compliance among chronic patients?Sapporo Med J2020; 54: 458.
21.
GautamVDileepanSRustagiN, et al. Health literacy, preventive COVID 19 behaviour and adherence to chronic disease treatment during lockdown among patients registered at primary health facility in urban Jodhpur, Rajasthan. Diabetes Metab Syndr: Clin Res Rev2021; 15: 205–211.
22.
SubathraGNRajendrababuSRSenthilkumarVA,et al.Impact of COVID-19 on follow-up and medication adherence in patients with glaucoma in a tertiary eye care centre in south India. Br J Med Biolog Res = Revista Brasileira de Pesquisas Medicas e Biologicas2021; 69: 1264–1270.
23.
DietrichFPolymerisAAVerbeekM, et al. Impact of the COVID-19 lockdown on the adherence of stroke patients to direct oral anticoagulants: a secondary analysis from the MAAESTRO study. J Neurol2021; 269: 1–7.
24.
ZhangH-QLinJ-YGuoY,et al.Medication adherence among patients with chronic obstructive pulmonary disease treated in a primary general hospital during the COVID-19 pandemic. Ann Transl Med2020; 8: 1179.
25.
MurrayKQuinnSTurkM, et al. COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population. Rheumatology2021; 60: 902–906.
26.
ShimelsTAsrat KassuRBogaleG, et al. Magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Ethiopia during the COVID-19 pandemic. PLoS One2021; 16: e0249222.
27.
BarnesAAndrewsJSpizzoP,et al.Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic. JGH Open2021; 5: 585–589.
28.
Oguz TopalIKara PolatAZindancıİ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: a multicenter study. J Cosmet Dermatol2022; 21: 39–47.
29.
Polat EkinciAPehlivanGGökalpMO. Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: a single-center experience. Dermatol Ther2021; 34: e14700.
30.
KayeLTheyeBSmeenkI,et al.Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol, Pract2020; 8: 2384–2385.
31.
Group* CHS. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med1991; 324: 150–154.
32.
GodinasLIyerKMeszarosG, et al. PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic. Orphanet J Rare Dis2021; 16: 1–9.
33.
ElbeddiniA. Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage. J Pharm Policy Pract2020; 13: 1–3.
34.
ChattopadhyayAMishraDSharmaV,et al.Coronavirus disease-19 and rheumatological disorders: a narrative.
35.
LiYHouSZhangY,et al.Effect of travel restrictions of Wuhan city against COVID-19: a modified SEIR model analysis. Disaster Med Public Health Prep2021: 1–7.
36.
RuksakulpiwatSZhouWChiaranaiC,et al.Human travelling and COVID-19 pandemic. Siriraj Med J2021; 73: 562–569.
37.
RomãoVCCordeiroIMacieiraC, et al. Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view. RMD open2020; 6: e001314.
38.
UmarSChybisovAMcCombK, et al. COVID-19 and access to cancer care in Kenya: patient perspective. Int J Cancer2021; 150: 1497–1503.
39.
GanapathyK. Telemedicine and neurological practice in the COVID-19 era. Neurol India2020; 68: 555.
40.
HincapiéMAGallegoJCGempelerA,et al.Implementation and usefulness of telemedicine during the COVID-19 pandemic: a scoping review. J Prim Care Community Health2020; 11: 2150132720980612.
41.
ArnoldRHTidemanPADevlinGP, et al. Rural and remote cardiology during the COVID-19 pandemic: Cardiac Society of Australia and New Zealand (CSANZ) consensus statement. Heart, Lung and Circulation2020; 29: e88–e93.
42.
AwwadMAMasoudM. Influence of COVID-19 on the prognosis and medication compliance of glaucoma patients in the Nile Delta region. Clin Ophthalmol2021; 15: 4565–4572.
43.
AhmedATKarterAJLiuJ. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabet Med2006; 23: 795–802.
44.
GhitzaUEWuL-TTaiB. Integrating substance abuse care with community diabetes care: implications for research and clinical practice. Subst Abuse Rehabil2013; 4: 3–10.
45.
ParsonsJTStarksTJMillarBM,et al.Patterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherence. Drug Alcohol Depend2014; 139: 33–40.
46.
SohlerNSlawekDEarnshawV, et al. Drug use and HIV medication adherence in people living with HIV. Subst Abus2021; 42: 310–316.
47.
TaylorSPaluszekMMRachorGS,et al.Substance use and abuse, COVID-19-related distress, and disregard for social distancing: a network analysis. Addict Behav2021; 114: 106754.
48.
CampbellANNunesEVMatthewsAG, et al. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry2014; 171: 683–690.
49.
NguyenTTNguyenMHPhamTTM, et al. Negative impacts of COVID-19 induced lockdown on changes in eating behavior, physical activity, and mental health as modified by digital healthy diet literacy and eHealth literacy. Front Nutr2021; 8: 774328.
50.
KendzerskaTZhuDTGershonAS, et al. The effects of the health system response to the COVID-19 pandemic on chronic disease management: a narrative review. Risk Manag Healthc Policy2021; 14: 575–584.
51.
OngJLLauTMassarSAA, et al. COVID-19-related mobility reduction: heterogenous effects on sleep and physical activity rhythms. Sleep2021; 44: zsaa179.
52.
SaahFIAmuHSeiduA-A,et al.Health knowledge and care seeking behaviour in resource-limited settings amidst the COVID-19 pandemic: a qualitative study in Ghana. Plos one2021; 16: e0250940.
53.
BrownMTBussellJK. Medication adherence: WHO cares?Mayo Clin Proc2011; 86: 304–314.
54.
ManiaciMJHeckmanMGDawsonNL. Functional health literacy and understanding of medications at discharge. Mayo Clin Proc2008: 554–558.
55.
Bin NaeemSKamel BoulosMN. COVID-19 misinformation online and health literacy: a brief overview. Int J Environ Res Public Health2021; 18: 8091.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
